Indoleamine 2,3-Dioxygenase (IDO) Inhibitor in Advanced Solid Tumors
Clinical trial NCT02048709 · COMPLETED
Trial details
- NCT number
- NCT02048709
- Sponsor
- Genentech, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2014-04-01
- Primary completion
- 2016-02-01
- Enrollment
- 22
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.